Cargando…

Rapid quantification assay of hepatitis B virus DNA in human serum and plasma by Fully Automated Genetic Analyzer μTASWako g1

Real-time monitoring of serum hepatitis B virus (HBV) levels is essential for the management of patients with chronic HBV infection in clinical practice, including monitoring the resistance of anti-HBV nucleotide analog or the detection of HBV reactivation. In this context, serum HBV deoxyribonuclei...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Moto, Toyoda, Hidenori, Kawabata, Tomohisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910706/
https://www.ncbi.nlm.nih.gov/pubmed/36758029
http://dx.doi.org/10.1371/journal.pone.0278143
_version_ 1784884841286729728
author Watanabe, Moto
Toyoda, Hidenori
Kawabata, Tomohisa
author_facet Watanabe, Moto
Toyoda, Hidenori
Kawabata, Tomohisa
author_sort Watanabe, Moto
collection PubMed
description Real-time monitoring of serum hepatitis B virus (HBV) levels is essential for the management of patients with chronic HBV infection in clinical practice, including monitoring the resistance of anti-HBV nucleotide analog or the detection of HBV reactivation. In this context, serum HBV deoxyribonucleic acid (DNA) quantification should be rapidly measured. A rapid HBV DNA quantification assay was established on the Fully Automated Genetic Analyzer, μTASWako g1. The assay performs automated sample preparation and DNA extraction, followed by the amplification and detection of quantitative polymerase chain reaction (PCR) combined with capillary electrophoresis (qPCR-CE) on integrated microfluidic chip. This study aimed to evaluate the analytical and clinical performance of HBV DNA assay on the μTASWako g1 platform in human serum and EDTA-plasma. The HBV DNA assay has a linear quantitative range from 20 to 10(8) IU/mL of HBV DNA with standard deviation (SD) of ≤0.14 log(10) IU/mL. The limits of detection of the assay were 4.18 for the serum and 4.35 for EDTA-plasma. The HBV assay demonstrated the equivalent performance in both human serum and EDTA-plasma matrices. The HBV genotypes A to H were detected with an accuracy of ±0.34 log(10) IU/mL. In quantification range, the HBV DNA assay was correlated with Roche cobas AmpliPrep/cobas TaqMan Ver2.0 (CAP/CTM v2) (r = 0.964). The mean difference (μTASWako g1–CAP/CTM v2) of the reported HBV DNA was −0.01 log(10) IU/mL. Overall, the sensitivity, accuracy, and precision of the μTASWako g1 HBV assay were comparable to the existing commercial HBV DNA assay, and the assay can be completed within 110 min. This evaluation suggests that the HBV DNA assay on the μTASWako g1 is potentially applied for alternative method of the HBV viral load test, in particular with the advantage of the HBV DNA result availability within 2 h, improving the HBV infection management.
format Online
Article
Text
id pubmed-9910706
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-99107062023-02-10 Rapid quantification assay of hepatitis B virus DNA in human serum and plasma by Fully Automated Genetic Analyzer μTASWako g1 Watanabe, Moto Toyoda, Hidenori Kawabata, Tomohisa PLoS One Research Article Real-time monitoring of serum hepatitis B virus (HBV) levels is essential for the management of patients with chronic HBV infection in clinical practice, including monitoring the resistance of anti-HBV nucleotide analog or the detection of HBV reactivation. In this context, serum HBV deoxyribonucleic acid (DNA) quantification should be rapidly measured. A rapid HBV DNA quantification assay was established on the Fully Automated Genetic Analyzer, μTASWako g1. The assay performs automated sample preparation and DNA extraction, followed by the amplification and detection of quantitative polymerase chain reaction (PCR) combined with capillary electrophoresis (qPCR-CE) on integrated microfluidic chip. This study aimed to evaluate the analytical and clinical performance of HBV DNA assay on the μTASWako g1 platform in human serum and EDTA-plasma. The HBV DNA assay has a linear quantitative range from 20 to 10(8) IU/mL of HBV DNA with standard deviation (SD) of ≤0.14 log(10) IU/mL. The limits of detection of the assay were 4.18 for the serum and 4.35 for EDTA-plasma. The HBV assay demonstrated the equivalent performance in both human serum and EDTA-plasma matrices. The HBV genotypes A to H were detected with an accuracy of ±0.34 log(10) IU/mL. In quantification range, the HBV DNA assay was correlated with Roche cobas AmpliPrep/cobas TaqMan Ver2.0 (CAP/CTM v2) (r = 0.964). The mean difference (μTASWako g1–CAP/CTM v2) of the reported HBV DNA was −0.01 log(10) IU/mL. Overall, the sensitivity, accuracy, and precision of the μTASWako g1 HBV assay were comparable to the existing commercial HBV DNA assay, and the assay can be completed within 110 min. This evaluation suggests that the HBV DNA assay on the μTASWako g1 is potentially applied for alternative method of the HBV viral load test, in particular with the advantage of the HBV DNA result availability within 2 h, improving the HBV infection management. Public Library of Science 2023-02-09 /pmc/articles/PMC9910706/ /pubmed/36758029 http://dx.doi.org/10.1371/journal.pone.0278143 Text en © 2023 Watanabe et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Watanabe, Moto
Toyoda, Hidenori
Kawabata, Tomohisa
Rapid quantification assay of hepatitis B virus DNA in human serum and plasma by Fully Automated Genetic Analyzer μTASWako g1
title Rapid quantification assay of hepatitis B virus DNA in human serum and plasma by Fully Automated Genetic Analyzer μTASWako g1
title_full Rapid quantification assay of hepatitis B virus DNA in human serum and plasma by Fully Automated Genetic Analyzer μTASWako g1
title_fullStr Rapid quantification assay of hepatitis B virus DNA in human serum and plasma by Fully Automated Genetic Analyzer μTASWako g1
title_full_unstemmed Rapid quantification assay of hepatitis B virus DNA in human serum and plasma by Fully Automated Genetic Analyzer μTASWako g1
title_short Rapid quantification assay of hepatitis B virus DNA in human serum and plasma by Fully Automated Genetic Analyzer μTASWako g1
title_sort rapid quantification assay of hepatitis b virus dna in human serum and plasma by fully automated genetic analyzer μtaswako g1
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910706/
https://www.ncbi.nlm.nih.gov/pubmed/36758029
http://dx.doi.org/10.1371/journal.pone.0278143
work_keys_str_mv AT watanabemoto rapidquantificationassayofhepatitisbvirusdnainhumanserumandplasmabyfullyautomatedgeneticanalyzermtaswakog1
AT toyodahidenori rapidquantificationassayofhepatitisbvirusdnainhumanserumandplasmabyfullyautomatedgeneticanalyzermtaswakog1
AT kawabatatomohisa rapidquantificationassayofhepatitisbvirusdnainhumanserumandplasmabyfullyautomatedgeneticanalyzermtaswakog1